| RS2530773035 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2530773151 |
MSH6
|
Health Risk |
Pathogenic |
Lynch syndrome 5, Lynch syndrome 5 |
| RS2530774036 |
SKIC3
|
Health Risk |
Pathogenic |
— |
| RS2530774225 |
MSH6
|
Health Risk |
Pathogenic |
Lynch syndrome 5, Lynch syndrome 5 |
| RS2530774334 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS2530774521 |
MSH6
|
Health Risk |
Pathogenic |
Lynch syndrome 5, Lynch syndrome 5 |
| RS2530774697 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2530775143 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2530775606 |
GRIA2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with language impairment and behavioral abnormalities, Neurodevelopmental disorder with language impairment and behavioral abnormalities |
| RS2530775655 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2530775670 |
GRIA2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with language impairment and behavioral abnormalities, Neurodevelopmental disorder with language impairment and behavioral abnormalities |
| RS2530775821 |
GRIA2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with language impairment and behavioral abnormalities, Neurodevelopmental disorder with language impairment and behavioral abnormalities |
| RS2530775972 |
FGB
|
Health Risk |
Likely pathogenic |
Familial dysfibrinogenemia, FGB-related disorder |
| RS2530775982 |
FBXW7
|
Health Risk |
Likely pathogenic |
Developmental delay, hypotonia |
| RS2530777027 |
MSH6
|
Health Risk |
Likely pathogenic |
Lynch syndrome, Lynch syndrome |
| RS2530777063 |
MSH6
|
Health Risk |
Likely pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS2530777857 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 5 |
| RS2530779091 |
SKIC3
|
Health Risk |
Likely pathogenic |
— |
| RS2530783457 |
GHR
|
Health Risk |
Likely pathogenic |
Laron-type isolated somatotropin defect, Laron-type isolated somatotropin defect |
| RS2530787207 |
FGB
|
Health Risk |
Likely pathogenic |
— |
| RS2530788030 |
FAT4
|
Health Risk |
Likely pathogenic |
— |
| RS2530796143 |
SKIC3
|
Health Risk |
Pathogenic |
— |
| RS2530796180 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2530796203 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2530796356 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2530796921 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2530796932 |
SKIC3
|
Health Risk |
Likely pathogenic |
— |
| RS2530796938 |
SKIC3
|
Health Risk |
Likely pathogenic |
— |
| RS2530798042 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2530798190 |
ADGRV1
|
Health Risk |
Likely pathogenic |
— |
| RS2530799093 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2530799214 |
MSH6
|
Health Risk |
Likely pathogenic |
Lynch syndrome 5, Lynch syndrome 5 |
| RS2530799433 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2530799547 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS2530799925 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2530800342 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2530800515 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2530801195 |
MSH6
|
Health Risk |
Pathogenic |
Lynch syndrome 5, Lynch syndrome 5 |
| RS2530801441 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome 5 |
| RS2530801524 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome 5 |
| RS2530801560 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2530801642 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2530802196 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2530802250 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2530802328 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2530802371 |
SKIC3
|
Health Risk |
Pathogenic |
— |
| RS2530802395 |
SKIC3
|
Health Risk |
Pathogenic |
— |
| RS2530802402 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS2530802502 |
SKIC3
|
Health Risk |
Pathogenic |
— |
| RS2530802580 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2530803426 |
MSH6
|
Health Risk |
Pathogenic |
Gastric cancer, Gastric cancer |
| RS2530803560 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS2530803610 |
MSH6
|
Health Risk |
Likely pathogenic |
— |
| RS2530803668 |
AP3B1
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 2, Hermansky-Pudlak syndrome 2 |
| RS2530804002 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome 5 |
| RS2530804099 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS2530804230 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2530804347 |
SKIC3
|
Health Risk |
Likely pathogenic |
— |
| RS2530804417 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome 5 |
| RS2530804487 |
MSH6
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Endometrial carcinoma |
| RS2530804564 |
MSH6
|
Health Risk |
Pathogenic |
Lynch syndrome 5, Hereditary nonpolyposis colorectal neoplasms |
| RS2530804790 |
MSH6
|
Health Risk |
Likely pathogenic |
Lynch syndrome 1, Lynch syndrome 1 |
| RS2530804830 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS2530805064 |
MSH6
|
Health Risk |
Pathogenic |
Lynch syndrome 5, Lynch syndrome 5 |
| RS2530805264 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2530805365 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2530805571 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2530805811 |
MSH6
|
Health Risk |
Pathogenic |
— |
| RS2530806423 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2530806721 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS2530808441 |
MCCC2
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS2530808483 |
MCCC2
|
Health Risk |
Conflicting classifications of pathogenicity |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS2530808635 |
MCCC2
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS2530808704 |
MCCC2
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS2530808873 |
SKIC3
|
Health Risk |
Pathogenic |
— |
| RS2530809001 |
MCCC2
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS2530812413 |
AP3B1
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 2, Hermansky-Pudlak syndrome 2 |
| RS2530812497 |
AP3B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hermansky-Pudlak syndrome 2, Hermansky-Pudlak syndrome 2 |
| RS2530813048 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2530813199 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2530815080 |
SKIC3
|
Health Risk |
Pathogenic |
— |
| RS2530815139 |
SKIC3
|
Health Risk |
Pathogenic |
— |
| RS2530815331 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2530815387 |
ADGRV1
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2C, Usher syndrome type 2C |
| RS2530817264 |
COL7A1
|
Health Risk |
Likely pathogenic |
Lung cancer, Recessive dystrophic epidermolysis bullosa |
| RS2530817698 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2530818610 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2530819182 |
FGA
|
Health Risk |
Likely pathogenic |
Familial dysfibrinogenemia, Familial dysfibrinogenemia |
| RS2530819504 |
FGA
|
Health Risk |
Pathogenic |
— |
| RS2530820233 |
FGA
|
Health Risk |
Pathogenic |
FGA-related disorder, FGA-related disorder |
| RS2530820313 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2530820376 |
FGA
|
Health Risk |
Likely pathogenic |
Familial dysfibrinogenemia, Familial visceral amyloidosis |
| RS2530820823 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2530820911 |
MCCC2
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS2530820915 |
MCCC2
|
Health Risk |
Pathogenic/Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS2530821025 |
MCCC2
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS2530821118 |
MCCC2
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS2530821547 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2530821984 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2530822515 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome 5 |